Bridging the gap between data scientist, clinicians and biologists using CRDC and CGC cloud resources
This April, the CGC Webinar Series features a talk by Dr. Daoud Meerzaman, Branch Chief of the Computational Genomics and Bioinformatics Branch (CGBB) at the Center for Biomedical Informatics & Information Technology (CBIIT), National Cancer Institute (NCI).
In this upcoming webinar, Dr. Meerzaman will talk about the Cancer Genomics Cloud (CGC) and the Cancer Research Data Commons (CRDC), and how these resources work together to bridge the gap between data scientists, clinicians and biologists. The recent explosion and ease of access to large-scale omics data provides a complex and vast framework for discovery. However, there are obstacles to optimal data management and analysis as the current bioinformatics tools require strong programming skills, but many scientists and clinicians do not have the expertise or the resources to go from data production, through bioinformatic and statistical analysis and ultimately clinical interpretation.
On April 28th, 2pm ET Dr. Meerzaman will highlight how the CGC can provide various approaches to mitigate these challenges. The CGC is a cloud based infrastructure that hosts data from different publicly available projects (such as the TCGA) and connects them with analytical tools to allow users to easily share, integrate, visualize and analyze these data.
Dr. Meerzaman has published over 50 articles and served as an invited reviewer for multiple peer-reviewed scientific journals. You can find some of his work in the following review in the AACR Cancer Research Journal and research paper in Nature Biotechnology.
More about the speaker
Dr. Daoud Meerzaman, CBIIT, NCI
Prior to joining NCI, Dr. Meerzaman worked as a clinical research fellow at the Children’s Hospital National Medical Center in Washington D.C., then served as a fellow in a joint program at the University of Maryland at Baltimore and Johns Hopkins University. Currently, he is serving as the branch chief for computational genomic and bioinformatics branch. Dr. Meerzaman received his bachelor’s degree and doctorate from George Washington University in Washington, D.C, where he currently serves as an adjunct professor and teaches Molecular Mechanisms of Cancer.
MORE ABOUT US AND THE CGC
Seven Bridges is the leading biomedical data company, specializing in software and data analytics to drive public and private healthcare research. We deliver end-to-end bioinformatic solutions — including access to datasets, analytic workflows and algorithms, cloud-computing infrastructure, and scientific support — that speed the path from raw experimental data to new treatments and diagnostics.
The Cancer Genomics Cloud (CGC), powered by Seven Bridges and funded by the National Cancer Institute, is a flexible cloud resource platform that enables storage, analysis, and computation of large cancer datasets in the cloud. Since its launch in 2016, the platform has been continuously iterated with new applications and features to address the exponential growth and diversity of complex datasets. With the CGC, any user with an account can easily access petabytes of data, share it, analyze and use the computational power of the cloud without having to learn how to program and get familiar with several different data portals.